Traceability of Biopharmaceuticals in Spontaneous Reporting Systems: A Cross-Sectional Study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance Databases

被引：0
|
作者：
Niels S. Vermeer
Sabine M. J. M. Straus
Aukje K. Mantel-Teeuwisse
Francois Domergue
Toine C. G. Egberts
Hubert G. M. Leufkens
Marie L. De Bruin
机构：
[1] Utrecht University,Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology
[2] Medicines Evaluation Board,Department of Clinical Pharmacy
[3] Medical Informatics,undefined
[4] Erasmus Medical Center,undefined
[5] European Medicines Agency,undefined
[6] University Medical Center Utrecht,undefined
来源：
Drug Safety | 2013年 / 36卷
关键词：
Small Molecule Drug; Batch Number; Spontaneous Reporting System; International Nonproprietary Name; Marketing Authorization Holder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：617 / 625
页数：8
相关论文
共 50 条
  • [1] Traceability of Biopharmaceuticals in Spontaneous Reporting Systems: A Cross-Sectional Study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance Databases
    Vermeer, Niels S.
    Straus, Sabine M. J. M.
    Mantel-Teeuwisse, Aukje K.
    Domergue, Francois
    Egberts, Toine C. G.
    Leufkens, Hubert G. M.
    De Bruin, Marie L.
    DRUG SAFETY, 2013, 36 (08) : 617 - 625
  • [2] Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
    He, Chang-Zhu
    Qiu, Qin
    Lu, Song-Jie
    Xue, Fu-Li
    Liu, Jun-Qiao
    He, Yu
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [3] Adverse Effects of Clopidogrel: a Cross Sectional Study of the FDA Adverse Event Reporting System Database
    Al-Saikhan, Fahad
    Ahmad, Nehad
    Abd-Elaziz, Mohamed
    Iqbal, Muhammad Shahid
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (07): : 1388 - 1391
  • [4] PEGylated versus non-PEGylated drugs: A cross-sectional analysis of adverse events in the FDA Adverse Event Reporting System (FAERS) Database
    Zhu, Zhengyi
    Gao, Peng
    Hu, Yan
    Wang, Junyan
    Wang, Huijuan
    Yang, Jufei
    Huang, Lingfei
    Ji, Cai
    Ni, Yinghua
    Fang, Luo
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (06) : 332 - 342
  • [5] A disproportionality analysis of sunitinib in the FDA adverse event reporting system (FAERS)
    Zou, Wenbin
    Yang, Han
    Xi, Yu
    Zeng, Chenxi
    Chen, Wei
    Fu, Xiangning
    HELIYON, 2024, 10 (17)
  • [6] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Chengwen Teng
    Christopher R. Frei
    Drugs - Real World Outcomes, 2022, 9 : 23 - 29
  • [7] Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Baus, Courtney
    Wilson, James P.
    Frei, Christopher R.
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (11): : 1504 - 1509
  • [8] Pharmacosurvellience Study of FDA Adverse Event Reporting System (FAERS) Events of Tofacitinib and Upadacitinib
    Barlas, Nur
    Barlas, Sait
    Milutinovic, Stefan
    Basnyat, Shristi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2058 - 2059
  • [9] Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
    Teng, Chengwen
    Frei, Christopher R.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 23 - 29
  • [10] A pharmacovigilance study of olanzapine/samidorphan based on FDA Adverse Event Reporting System (FAERS)
    He, Luyao
    Shen, Mengting
    Zhang, Lei
    Li, Yan
    Li, Huafang
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
12345